Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Participants currently using estrogen-containing contraception, compared with non-users, also tended to have higher median 25(OH)D concentrations as well as lower frequency of anemia (hemoglobin <12 g/dl) and ever use of DMPA in the past.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1693 Black women ages 23 to 35 years enrolled in years 2010 to 2012.
Source: Abstract.
As the SELF data were de-identified at Michigan State University, the conduct of research for the present study was deemed not to involve human subjects by the Human Research Protections Program (institutional review board).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Estrogen-containing contraceptive use and blood lead concentrations in a cohort of premenopausal individuals
Cross-sectional study · Environmental research · 2025
Original publication title
Estrogen-containing contraceptive use and blood lead concentrations in a cohort of premenopausal individuals
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
After exposure, toxic metal lead is stored in the skeleton and is mobilized to systemic circulation with bone turnover. Given the bone-conserving properties of estrogen, we investigated whether current use of estrogen-containing contraception is associated with lower blood lead concentrations. We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1693 Black women ages 23 to 35 years enrolled in years 2010 to 2012. The study population was restricted to non-users of injectable hormonal contraception with questionnaire data on hormonal contraceptive use and laboratory data on whole blood lead concentrations (n = 1549).
The geometric mean blood lead concentrations for current users of estrogen-containing contraception and non-users were 0.41 μg/dl (95 % CI: 0.39 to 0.43) and 0.51 μg/dl (95 % CI: 0.50 to 0.52), respectively. After adjusting for age, education, current smoking status, alcohol consumption, recency of injectable contraceptive hormone use, and recent birth using a multivariable linear regression model to estimate the percent difference in blood lead concentrations, current use of estrogen-containing contraception was associated with an 11 % lower blood-lead concentrations (95 % CI: −16 %, −5 %).
In exploratory analyses considering contraceptive type, current combined oral contraceptive users (n = 187) had 10 % lower blood lead concentrations (95 % CI: −16 %, −4 %) and contraceptive vaginal ring/transdermal patch users (n = 33) had 18 % lower blood lead concentrations (95 % CI: −29 %, −5 %) compared with non-users. Given the known toxic effects of lead and the common use of estrogen-containing contraception, further research is warranted to confirm our observation of lower blood lead concentrations with current use of estrogen-containing contraception.
Authors’ abstract
After exposure, toxic metal lead is stored in the skeleton and is mobilized to systemic circulation with bone turnover. Given the bone-conserving properties of estrogen, we investigated whether current use of estrogen-containing contraception is associated with lower blood lead concentrations. We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1693 Black women ages 23 to 35 years enrolled in years 2010 to 2012. The study population was restricted to non-users of injectable hormonal contraception with questionnaire data on hormonal contraceptive use and laboratory data on whole blood lead concentrations (n = 1549).
The geometric mean blood lead concentrations for current users of estrogen-containing contraception and non-users were 0.41 μg/dl (95 % CI: 0.39 to 0.43) and 0.51 μg/dl (95 % CI: 0.50 to 0.52), respectively. After adjusting for age, education, current smoking status, alcohol consumption, recency of injectable contraceptive hormone use, and recent birth using a multivariable linear regression model to estimate the percent difference in blood lead concentrations, current use of estrogen-containing contraception was associated with an 11 % lower blood-lead concentrations (95 % CI: −16 %, −5 %).
In exploratory analyses considering contraceptive type, current combined oral contraceptive users (n = 187) had 10 % lower blood lead concentrations (95 % CI: −16 %, −4 %) and contraceptive vaginal ring/transdermal patch users (n = 33) had 18 % lower blood lead concentrations (95 % CI: −29 %, −5 %) compared with non-users. Given the known toxic effects of lead and the common use of estrogen-containing contraception, further research is warranted to confirm our observation of lower blood lead concentrations with current use of estrogen-containing contraception.
Publication and source details
Original title: Estrogen-containing contraceptive use and blood lead concentrations in a cohort of premenopausal individuals
Lauren E. Chapman; Mandy S. Hall; Arianna Foster; Donna D. Baird; Quaker E. Harmon; Robert O. Wright; Julio A. Landero; Renee Heffron; Lauren A. Wise; Ganesa Wegienka; Ruth J. Geller; Amelia K. Wesselink; Samantha Schildroth; Janet E. Hall; Erik J. Tokar; Kristen Upson
Environmental research · 2025
* Corresponding author. upsonkri@msu.edu (K. Upson).https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T02:47:56.163728+00:00
DOI: 10.1016/j.envres.2025.122935 · PMC12900035